MaxCyte, Inc. (MXCT) vs Owlet, Inc. (OWLT)
- MaxCyte, Inc. MXCT 1.30 0.00%
- Owlet, Inc. OWLT 4.14 −6.76%
MaxCyte, Inc. and Owlet, Inc. are both Medical Devices companies. MaxCyte, Inc. and Owlet, Inc. are of similar size ($134.2M and $129.8M). Owlet, Inc. grew revenue faster over the last twelve months: 28.0% against −13.2%. Owlet, Inc. has the higher net margin (−10.7% vs −114.8%) and the higher return on invested capital (−27.6% vs −49.2%). Across the 18 metrics below, Owlet, Inc. leads on 12 and MaxCyte, Inc. on 6.
Valuation
Profitability
| Metric | MXCT | OWLT | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.23% | 54.75% | 56.01% |
| Operating margin | (134.59%) | (6.67%) | (15.03%) |
| Net margin | (114.77%) | (10.67%) | (20.40%) |
| Free cash flow margin | (76.14%) | (8.59%) | (7.24%) |
| Return on equity | (20.39%) | 68.03% | (15.32%) |
| Return on assets | (17.62%) | (15.60%) | (19.72%) |
| Return on invested capital | (49.23%) | (27.60%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack